Genotoxicity assessment of the antiepileptic drug AMP397, an Ames-positive aromatic nitro compound.

AMP397 is a novel antiepileptic agent and the first competitive AMPA antagonist with high receptor affinity, good in vivo potency, and oral activity. AMP397 has a structural alert (aromatic nitro group) and was mutagenic in Salmonella typhimurium strains TA97a, TA98 and TA100 without S9, but negative in the nitroreductase-deficient strains TA98NR and TA100NR. The amino derivative of AMP397 was negative in wild-type strains TA98 and TA100. AMP397 was negative in a mouse lymphoma tk assay, which included a 24h treatment without S9. A weak micronucleus induction in vitro was found at the highest concentrations tested in V79 cells with S9. AMP397 was negative in the following in vivo studies, which included the maximum tolerated doses of 320mg/kg in mice and 2000mg/kg in rats: MutaMouse assay in colon and liver (5x320mg/kg) at three sampling times (3, 7 and 31 days after the last administration); DNA binding study in the liver of mice and rats after a single treatment with [14C]-AMP397; comet assay (1x2000mg/kg) in jejunum and liver of rats, sampling times 3 and 24h after administration; micronucleus test (2x320mg/kg) in the bone marrow of mice, sampling 24h after the second administration. Based on these results, it was concluded that AMP397 has no genotoxic potential in vivo. In particular, no genotoxic metabolite is formed in mammalian cells, and, if formed by intestinal bacteria, is unable to exert any genotoxic activity in the adjacent intestinal tissue. These data were considered to provide sufficient safety to initiate clinical development of the compound.

[1]  F. Beland,et al.  S9-mediated metabolism of 1-nitropyrene to a mutagen in Chinese hamster ovary cells by ring-oxidation under aerobic conditions and by nitroreduction under anaerobic conditions. , 1991, Carcinogenesis.

[2]  W. Lutz.  Quantitative evaluation of DNA binding data for risk estimation and for classification of direct and indirect carcinogens , 2004, Journal of Cancer Research and Clinical Oncology.

[3]  W. Löscher.  Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy , 1998, Progress in Neurobiology.

[4]  C. W. von der Lieth,et al.  The structural basis for the mutagenicity of aristolochic acid. , 1990, Cancer letters.

[5]  P. Olive,et al.  Cell proliferation as a requirement for development of the contact effect in Chinese hamster V79 spheroids. , 1989, Radiation research.

[6]  J. Vijg,et al.  A selective system for lacZ- phage using a galactose-sensitive E. coli host. , 1993, BioTechniques.

[7]  R. Fisher,et al.  The impact of epilepsy from the patient’s perspective II: views about therapy and health care , 2000, Epilepsy Research.

[8]  T. Halonen,et al.  A crucial role of the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid subtype of glutamate receptors in piriform and perirhinal cortex for the initiation and propagation of limbic motor seizures. , 1997, The Journal of pharmacology and experimental therapeutics.

[9]  D. Horvat,et al.  The mutagenicity of nitroaromatic drugs: effect of metronidazole after incubation in hypoxia in vitro. , 1980, Mutation research.

[10]  S. Tsuda,et al.  The Comet Assay with Multiple Mouse Organs: Comparison of Comet Assay Results and Carcinogenicity with 208 Chemicals Selected from the IARC Monographs and U.S. NTP Carcinogenicity Database** , 2000, Critical reviews in toxicology.

[11]  A. Basu,et al.  Mutagenicity of nitroaromatic compounds. , 2000, Chemical research in toxicology.

[12]  I. Rowland.  Factors affecting metabolic activity of the intestinal microflora. , 1988, Drug metabolism reviews.

[13]  F Romagna,et al.  The automated bone marrow micronucleus test. , 1989, Mutation research.

[14]  J. Vijg,et al.  Application of galactose-sensitive E. coli strains as selective hosts for LacZ- plasmids. , 1992, Nucleic acids research.

[15]  D E Rickert,et al.  Metabolism of nitroaromatic compounds. , 1987, Drug metabolism reviews.

[16]  Technical aspects of automatic micronucleus analysis in rodent bone marrow assays , 1994, Cell Biology and Toxicology.

[17]  G. Speit,et al.  The Comet Assay (Single-Cell Gel Test) , 1999 .

[18]  P. Fu,et al.  Metabolism of 1-nitrobenzo[a]pyrene by rat liver microsomes to potent mutagenic metabolites. , 1986, Carcinogenesis.

[19]  R. Sram,et al.  Genotoxicity and carcinogenicity of metronidazole. , 1994, Mutation research.

[20]  B. Ames,et al.  Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Plewa,et al.  Mutagenicity of selected aniline derivatives to Salmonella following plant activation and mammalian hepatic activation. , 1987, Mutation research.

[22]  D. Menendez,et al.  DNA breakage due to metronidazole treatment. , 2001, Mutation research.

[23]  J. Tocher.  Reductive activation of nitroheterocyclic compounds. , 1997, General pharmacology.

[24]  Bruce Hermann,et al.  The impact of epilepsy from the patient’s perspective I. Descriptions and subjective perceptions , 2000, Epilepsy Research.

[25]  R. Tennant,et al.  Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP. , 1988, Mutation research.

[26]  C. Wolf,et al.  Endogenous xenobiotic enzyme levels in mammalian cells. , 1991, Mutation research.

[27]  T. Sugimura,et al.  Carcinogenic action of 4-nitroquinoline-N-oxide. , 1957, Gan.

[28]  R. Tice,et al.  Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing , 2000, Environmental and molecular mutagenesis.

[29]  C. Schlatter,et al.  DNA methylation in rat liver by daminozide, 1,1-dimethylhydrazine, and dimethylnitrosamine. , 1988, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[30]  F. Staedtler,et al.  System issues: Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue™ transgenic mouse mutation assay , 1996 .

[31]  S Albertini,et al.  Comparative evaluation of the in vitro micronucleus test and the in vitro chromosome aberration test: industrial experience. , 1997, Mutation research.

[32]  G. Winston,et al.  Dinitropyrene nitroreductase activity of purified NAD(P)H-quinone oxidoreductase: role in rat liver cytosol and induction by Aroclor-1254 pretreatment. , 1991, Carcinogenesis.

[33]  B. Ames,et al.  Revised methods for the Salmonella mutagenicity test. , 1983, Mutation research.

[34]  W Frieauff,et al.  Automatic analysis of slides processed in the Comet assay. , 2001, Mutagenesis.

[35]  Pederson Tc,et al.  The activation of mutagens in diesel particle extract with rat liver S9 enzymes. , 1981 .

[36]  Y. Minabe,et al.  Acute effects of various GABA receptor agonists and glutamate antagonists on focal hippocampal seizures in freely moving rats elicited by low‐frequency stimulation , 1998, Synapse.

[37]  C. Schlatter,et al.  The relevance of covalent binding to mouse liver DNA to the carcinogenic action of hexachlorocyclohexane isomers. , 1983, Carcinogenesis.

[38]  P. Kwan,et al.  Early identification of refractory epilepsy. , 2000, The New England journal of medicine.

[39]  F. Beland,et al.  Formation of DNA adducts in vitro and in Salmonella typhimurium upon metabolic reduction of the environmental mutagen 1-nitropyrene. , 1983, Cancer research.

[40]  M. Engelke,et al.  Reinvestigation of in vivo genotoxicity studies in man. I. No induction of DNA strand breaks in peripheral lymphocytes after metronidazole therapy. , 1997, Mutation research.

[41]  W. Campbell,et al.  The role of intestinal microflora in the metabolic activation of 6-nitrochrysene to DNA-binding derivatives in mice. , 1990, Toxicology.

[42]  M. Hofnung,et al.  Short-term infection with Helicobacter pylori and 1 week exposure to metronidazole does not enhance gastric mutation frequency in transgenic mice. , 2000, The Journal of antimicrobial chemotherapy.

[43]  H. Rosenkranz,et al.  Evidence for the existence of distinct nitroreductases in Salmonella typhimurium: roles in mutagenesis. , 1982, Carcinogenesis.

[44]  W. Lutz,et al.  In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis. , 1979, Mutation research.